Venture Capital

Bluepoint Partners

Investment Details

Investor Type
Venture Capital

Asset Class Focus
Venture Capital

Stage Focus
Seed, Early Stage, Growth

Geographical Focus
South Korea

Industries Focus

  • Technology
  • Healthcare
  • Biotech
  • Clean Tech
  • Industrial Technology
  • Data and Artificial Intelligence

Investment Size:
1,000,000 to 10,000,000 USD

Investor Details Founded: 2013

Bluepoint Partners is a South Korean venture capital firm specializing in early-stage investments in technology and industrial sectors. The firm focuses on supporting high-tech entrepreneurs in launching innovative startups with global solutions. They work closely with entrepreneurs, providing them with the necessary resources, connections, and capital to bring their visions to life. With offices in Daejeon and Seoul, Bluepoint Partners is deeply committed to the high-tech communities in these areas. They also host workshops and private events to connect their entrepreneurs with strategic relationships, VCs, talent, advisors, and press. Bluepoint Partners prides itself on forming deep relationships with their entrepreneurs and creating a supportive Bluepoint Family.

In July 2025, Bluepoint Partners unveiled 'Studiobi,' a startup collaboration platform designed to foster innovation between large and mid-sized companies and startups. This initiative aims to bridge the gap between established corporations and emerging startups, facilitating strategic partnerships and open innovation. The platform offers solutions such as proof of concept (PoC) projects and dedicated funds, enabling companies to leverage startup methodologies and processes to drive growth and efficiency.

As of the first half of 2022, Bluepoint Partners had invested in 255 startups across various sectors, including digital, industrial technology, data and artificial intelligence, healthcare, bio and medical, and clean tech. The total corporate value of Bluepoint's portfolio was approximately 4,458 billion won ($3.1 billion). Notable portfolio companies include Plasmap, a manufacturer of medical sterilizers; Tomocube, a developer of 3D microscopes; and Starstech, a manufacturer of eco-friendly snow removers using starfish.

Bluepoint Partners continues to play a pivotal role in accelerating the growth of technology-based startups in South Korea, fostering innovation, and contributing to the global competitiveness of its portfolio companies.

Requirements
  • Innovative technology
  • Global impact
  • Strong intellectual property
  • Product-market fit
  • Global market potential
  • Execution capability
Contact

[Official Website Hidden]

[HQ Location Hidden]

[Email Hidden]

Portfolio Companies
  • Plasmap
  • Tomocube
  • Starstech
Claim this Investor

Are you an official representative of Bluepoint Partners?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim